• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测4期慢性肾脏病患者的死亡率及肾脏替代治疗的接受情况。

Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.

作者信息

Conway Bryan, Webster Angela, Ramsay George, Morgan Neal, Neary John, Whitworth Caroline, Harty John

机构信息

Department of Renal Medicine, Royal Infirmary Edinburgh, Edinburgh, UK.

出版信息

Nephrol Dial Transplant. 2009 Jun;24(6):1930-7. doi: 10.1093/ndt/gfn772. Epub 2009 Jan 30.

DOI:10.1093/ndt/gfn772
PMID:19181760
Abstract

BACKGROUND

Novel strategies are required to efficiently manage the increasing number of patients diagnosed with chronic kidney disease (CKD). We sought to identify factors predicting outcome in patients with stage 4 CKD and to determine whether low-risk patients could be managed in primary care.

METHODS

We performed a two-centre, retrospective cohort study including 396 patients with stage 4 CKD referred to nephrology clinics from 1998 to 2002. We utilized electronic databases to determine the incidence of renal replacement therapy (RRT) and mortality and the rate of deterioration in estimated glomerular filtration rate (eGFR) to the year end 2005.

RESULTS

This was an elderly cohort, with 71.7% of patients aged > or =65 years. The risk of surviving to require dialysis fell with increasing age (HR 0.44; 95% CI: 0.23-0.84 for those >74 years verses those <65 years), in part due to the slower rate of decline in renal function in older patients (median fall in eGFR was -2.25, -1.38 and -0.86 ml/ min/1.73 m(2)/year in those aged <65 years, 65-74 years and >74 years, respectively, P < 0.0001). Additional independent risk factors predicting RRT included: high baseline proteinuria (HR 6.26; 95% CI: 2.74-14.23 for >3 g/24 h versus <0.3 g/24 h), greater early decline in renal function (HR 3.86; 95% CI: 2.34-6.38 for > or =4 ml/min/1.73 m(2)/year versus <4 ml/min/1.73 m(2)/year), low baseline eGFR (HR 2.92; 95% CI: 1.61-5.30 for 15-19 versus 25-29 ml/min/1.73 m(2)) and low haemoglobin (HR 3.16; 95% CI: 1.64-6.08 for <10 versus >12 g/dl). The 98 (24.7%) patients discharged to primary care had more stable renal function than those remaining under nephrology care (median change in eGFR of +0.20 versus -1.88 ml/ min/1.73 m(2)/year, P = 0.0001).

CONCLUSIONS

Most patients with stage 4 CKD, in particular the elderly, die without commencing RRT. Patients at low risk of progression can be identified and discharged safely to primary care with an active management plan.

摘要

背景

需要新的策略来有效管理诊断为慢性肾脏病(CKD)的患者数量不断增加的情况。我们试图确定预测4期CKD患者预后的因素,并确定低风险患者是否可以在初级保健中进行管理。

方法

我们进行了一项双中心回顾性队列研究,纳入了1998年至2002年转诊至肾脏病诊所的396例4期CKD患者。我们利用电子数据库确定至2005年底肾替代治疗(RRT)的发生率、死亡率以及估计肾小球滤过率(eGFR)的恶化率。

结果

这是一个老年队列,71.7%的患者年龄≥65岁。随着年龄增长,存活至需要透析的风险降低(74岁及以上患者与65岁以下患者相比,风险比[HR]为0.44;95%置信区间[CI]:0.23 - 0.84),部分原因是老年患者肾功能下降速度较慢(eGFR的中位数下降分别为:65岁以下患者为 - 2.25,65 - 74岁患者为 - 1.38,74岁及以上患者为 - 0.86 ml/min/1.73 m²/年,P < 0.0001)。预测RRT的其他独立风险因素包括:高基线蛋白尿(24小时尿蛋白>3 g与<0.3 g相比,HR为6.26;95% CI:2.74 - 14.23)、肾功能早期下降幅度更大(eGFR下降≥4 ml/min/1.73 m²/年与<4 ml/min/1.73 m²/年相比,HR为3.86;95% CI:2.34 - 6.38)、低基线eGFR(15 - 19与25 - 29 ml/min/1.73 m²相比,HR为2.92;95% CI:1.61 - 5.30)以及低血红蛋白(血红蛋白<10 g/dl与>12 g/dl相比,HR为3.16;95% CI:1.64 - 6.08)。出院至初级保健的98例(24.7%)患者肾功能比仍接受肾脏病护理的患者更稳定(eGFR的中位数变化为+0.20与 - 1.88 ml/min/1.73 m²/年,P = 0.0001)。

结论

大多数4期CKD患者,尤其是老年患者,未开始RRT就死亡。可以识别出进展风险低的患者,并通过积极的管理计划安全地将其出院至初级保健。

相似文献

1
Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.预测4期慢性肾脏病患者的死亡率及肾脏替代治疗的接受情况。
Nephrol Dial Transplant. 2009 Jun;24(6):1930-7. doi: 10.1093/ndt/gfn772. Epub 2009 Jan 30.
2
Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.晚期慢性肾脏病老年人群的死亡风险增加:台湾的一项队列研究
Nephrol Dial Transplant. 2008 Oct;23(10):3192-8. doi: 10.1093/ndt/gfn222. Epub 2008 May 1.
3
Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.影响选择不接受透析的晚期慢性肾病患者生存的因素。
Ren Fail. 2007;29(6):653-9. doi: 10.1080/08860220701459634.
4
Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?肾小球滤过率的评估:血红蛋白能否区分衰老与真正的慢性肾脏病?
Nephrol Dial Transplant. 2009 Jun;24(6):1828-33. doi: 10.1093/ndt/gfn738. Epub 2009 Jan 8.
5
Anaemia is common and predicts mortality in diabetic nephropathy.贫血在糖尿病肾病中很常见,并且是死亡率的预测指标。
QJM. 2007 Oct;100(10):641-7. doi: 10.1093/qjmed/hcm080.
6
Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.肾病科转诊前后肾功能的下降及其对中重度慢性肾脏病患者生存的影响。
Nephrol Dial Transplant. 2006 Aug;21(8):2133-43. doi: 10.1093/ndt/gfl198. Epub 2006 Apr 27.
7
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.肥胖对非糖尿病慢性肾脏病进展的影响:一项回顾性队列研究。
Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.
8
Predicting renal replacement therapy and mortality in CKD.预测慢性肾脏病患者的肾脏替代治疗及死亡率
Am J Kidney Dis. 2007 Oct;50(4):559-65. doi: 10.1053/j.ajkd.2007.07.006.
9
Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.在南加州凯撒医疗机构实施美国肾脏病预后质量倡议(KDOQI)的慢性肾脏病(CKD)定义及分期指南。
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S86-99. doi: 10.1053/j.ajkd.2008.07.052.
10
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.蛋白尿、慢性肾病以及血管紧张素受体阻滞剂联合血管紧张素转换酶抑制剂对中重度心力衰竭患者的影响
Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

引用本文的文献

1
Renal aging and its consequences: navigating the challenges of an aging population.肾脏衰老及其后果:应对老龄化人口带来的挑战。
Front Pharmacol. 2025 Jul 24;16:1615681. doi: 10.3389/fphar.2025.1615681. eCollection 2025.
2
Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study.德国慢性肾脏病进展和死亡风险概况:来自慢性肾脏病结局和实践模式研究的结果。
Nephrol Dial Transplant. 2020 May 1;35(5):803-810. doi: 10.1093/ndt/gfz260.
3
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care.
接受稳定肾脏科护理的非透析慢性肾脏病患者中高钾血症状态导致死亡和终末期肾病的竞争风险分析
J Clin Med. 2018 Dec 1;7(12):499. doi: 10.3390/jcm7120499.
4
Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis.慢性肾脏病患者透析前期肾功能的下降:一项系统评价和荟萃分析。
Clin Epidemiol. 2018 May 25;10:613-622. doi: 10.2147/CLEP.S153367. eCollection 2018.
5
Prediction Model and Risk Stratification Tool for Survival in Patients With CKD.慢性肾脏病患者生存的预测模型与风险分层工具
Kidney Int Rep. 2017 Nov 28;3(2):417-425. doi: 10.1016/j.ekir.2017.11.010. eCollection 2018 Mar.
6
Treatment decisions for older adults with advanced chronic kidney disease.老年晚期慢性肾脏病患者的治疗决策
BMC Nephrol. 2017 Jun 19;18(1):200. doi: 10.1186/s12882-017-0617-3.
7
Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients.老年3期和4期慢性肾病患者的肾病进展
Int Urol Nephrol. 2017 Jun;49(6):1033-1040. doi: 10.1007/s11255-017-1543-9. Epub 2017 Feb 24.
8
Peritoneal Dialysis for Heart Failure.心力衰竭的腹膜透析
Perit Dial Int. 2015 Nov;35(6):645-9. doi: 10.3747/pdi.2014.00340.
9
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question.肾脏病学护理下的5期慢性肾脏病:透析与否,这是个问题。
J Nephrol. 2016 Apr;29(2):153-161. doi: 10.1007/s40620-015-0243-8. Epub 2015 Nov 19.
10
Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients.在体弱和老年患者中使用替代透析方案的支持与反对观点。
Int Urol Nephrol. 2015 Nov;47(11):1809-16. doi: 10.1007/s11255-015-1107-9. Epub 2015 Sep 16.